Contineum Therapeutics, Inc.
NASDAQContineum Therapeutics heads into its May 7 Q1 2026 results with short sellers holding a meaningful position — but options traders telling a noticeably different story. Short interest is a genuine factor here. At 13.5% of the free float, it has climbed roughly 16% over the past month, with a sharp step up around April 24 when shares jumped from ~2.83 million to ~3.12 million short…
Snapshot as of 6 May 2026
Contineum Therapeutics heads into its May 7 Q1 2026 results with short sellers holding a meaningful position — but options traders telling a noticeably different story. Short interest is a genuine factor here. At 13.5%…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CTNM — free to start on ORTEX.
Sign up for free →Open CTNM on ORTEX